drugset / Trial / NCT07634068

Vertebrobasilar Dolichoectasia Treatment With Amiloride

NCT07634068

Phase 2 Not yet recruiting 6 enrolled Huashan Hospital
NaSingle-groupOpen-labelTreatment

Summary

The aim of this pilot study is to assess the efficacy of amiloride in reducing wall enhancement in vertebrobasilar dolichoectasia(VBD) on high-resolution magnetic resonance vessel wall imaging(HR-VWI) via anti-inflammatory mechanisms, clarify the efficacy of amiloride in delaying the progression of VBD, evaluate the safety of amiloride in the treatment of VBD.

Timeline

Start
2026-06
Primary completion
2027-06
Completion
2027-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Amiloride Small molecule 2.5 mg Oral
Subject Hydrochlorothiazide Unknown 25 mg Oral